Human and animal intestinal commensals and probiotics vs modern challenges of biosafety: problems and prospects

Document Type : Mini Review

Authors

1 Kazan Institute of Biochemistry and Biophysics of the Kazan Scientific Center of the Russian Academy of Sciences, Kazan, Russian Federation

2 Kazan Federal University

10.32592/ARI.2024.79.1.28

Abstract

The appearance of an array of data on the study of the intestinal microbiota in Metazoa has significantly expanded our understanding of the role of commensals in the control of a wide range of physiological functions in higher organisms in norm and pathology. In the intestine, where the microbial load significantly exceeds the number of microorganisms of other ecosystems, the components of the intestinal microbiota are a constant source of stimuli that induce activation of the host immune systemThe introduction into practice of biomedical research of innovative high-resolution methods, including multi-omix technologies, has brought data that change our understanding of intestinal commensals, including probiotics with GRAS status, widely used in medicine, agriculture and biotechnology. The ability of these bacteria to induce negative processes in the host body that are beneficial for bacterial proliferation and expansion revealed a clear lack of our knowledge about the logic of their life and the mechanisms of interaction with eukaryotic cells. This determines the urgent need for comprehensive research of probiotics and the development of standardization of their safety assessment. Apriori's confidence in the exceptional benefit of the bacteria widely used in medicine, agriculture and biotechnology has determined the seriously omission in our control system today - the lack of standardization of studies for the safety assessment of bacteria with GRAS status . The moment has come when it became clear that this gap should be promptly filled and that only exact understanding the molecular base of interacting the microbes with eukaryotic cells can provide the foundation for effective practical developments in controlling the evolution of bacterial virulence and probiotic safety strategy, as well as the competent use of genetic technologies for monitoring the environment and managing infectious processes, thus avoiding the dramatic consequences of large-scale interventions in the micro and macro worlds.

Keywords

Main Subjects


References
1. Westermann AJ, Vogel J. Cross-species RNA-seq for
deciphering host-microbe interactions // Nat Rev Genet.
2021 Jun;22(6):361-378.
2. Hooper LV, Littman DR, Macpherson AJ. Interactions
between the microbiota and the immune system // Science.
2012 Jun 8;336(6086):1268-73.
3. Sebastián Domingo JJ, Sánchez Sánchez C. From the
intestinal flora to the microbiome. // Rev Esp Enferm Dig.
2018 Jan;110(1):51-56.
4. Postler TS, Ghosh S. Understanding the Holobiont: How
Microbial Metabolites Affect Human Health and Shape the
Immune System // Cell Metab. 2017 Jul 5;26(1):110-130.
5. Marchesi JR. Advancing microbiome research //
Microbiology (Reading). 2018;164(8):1005-1006.
6. Doron S, Snydman DR. Risk and safety of probiotics //
Clin Infect Dis. 2015; 60 Suppl 2(Suppl 2):S129-34.
7. Bodke H, Jogdand S. Role of Probiotics in Human
Health // Cureus. 2022 Nov 9;14(11):e31313.
8. Rosenberg E, Zilber-Rosenberg I. The hologenome
concept of evolution after 10 years // Microbiome.
2018;6(1):78.
32 Chernov et al / Archives of Razi Institute, Vol. 79, No. 1 (2024) 28-32
9. Diard M, Hardt WD. Evolution of bacterial virulence //
FEMS Microbiol Rev. 2017;41(5):679-697.
10. Mendes I, Vale N How Can the Microbiome Induce
Carcinogenesis and Modulate Drug Resistance in Cancer
Therapy? // Int J Mol Sci. 2023;24(14):11855.
11. Xu W, Fang Y, Hu Q, Zhu K. Emerging Risks in Food:
Probiotic Enterococci Pose a Threat to Public Health
through the Food Chain // Foods. 2021 ;10(11):2846.
12. Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN,
Shang A, Xu XY, Li HB. Effects and Mechanisms
of Probiotics, Prebiotics, Synbiotics, and Postbiotics on
Metabolic Diseases Targeting Gut Microbiota: A Narrative
Review. // Nutrients. 2021;13(9):3211.
13. Sukhvinder Gill, Ryan Catchpole, Patrick Forterre
Extracellular membrane vesicles in the three domains of
life and beyond //FEMS Microbiol Rev. 2019; 43(3): 273–
303.
14. Alexander LM, van Pijkeren JP. Modes of therapeutic
delivery in synthetic microbiology // Trends Microbiol.
2023;31(2):197-211.
15. Tian CM, Yang MF, Xu HM, Zhu MZ, Zhang Y, Yao
J, Wang LS, Liang YJ, Li DF. Emerging role of bacterial
outer membrane vesicle in gastrointestinal tract // Gut
Pathog. 2023;15(1):20.
16. Li XY, Zeng ZX, Cheng ZX, Wang YL, Yuan LJ, Zhai
ZY, Gong W. Common pathogenic bacteria-induced
reprogramming of the host proteinogenic amino acids
metabolism. Amino Acids. 2023 Oct 9. Epub ahead of
print. PMID: 37814028.
17. Gottfried S, Koloamatangi SMBMJ, Daube C,
Schiemann AH, Sattlegger E. A genetic approach to
identify amino acids in Gcn1 required for Gcn2 activation
// PLoS One. 2022;17(11):e0277648.
18. Ghosh JC, Perego M, Agarwal E, Bertolini I, Wang Y,
Goldman AR, Tang HY, Kossenkov AV, Landis CJ,
Languino LR, Plow EF, Morotti A, Ottobrini L, Locatelli
M, Speicher DW, Caino MC, Cassel J, Salvino JM, Robert
ME, Vaira V, Altieri DC Ghost mitochondria drive
metastasis through adaptive GCN2/Akt therapeutic
vulnerability // Proc Natl Acad Sci U S A.
2022;119(8):e2115624119.
19. Markova ND. L-form bacteria cohabitants in human
blood: significance for health and diseases // Discov Med.
2017; 23(128):305-313.
20. Errington J. Cell wall-deficient, L-form bacteria in the
21st century: a personal perspective // Biochem Soc Trans.
2017;45(2):287-295.
21. Kostenko VV, Mouzykantov AA, Baranova NB,
Boulygina EA, Markelova MI, Khusnutdinova DR, Trushin
MV, Chernova OA, Chernov VM. Development of
Resistance to Clarithromycin and Amoxicillin-Clavulanic
Acid in Lactiplantibacillus plantarum In Vitro Is Followed
by Genomic Rearrangements and Evolution of Virulence.
Microbiol Spectr. 2022 Jun 29;10(3):e0236021. Epub 2022
May 17. PMID: 35579444; PMCID: PMC9241834.
22. Merenstein D, Pot B, Leyer G, Ouwehand AC, Preidis
GA, Elkins CA, Hill C, Lewis ZT, Shane AL, Zmora N,
Petrova MI, Collado MC, Morelli L, Montoya GA,
Szajewska H, Tancredi DJ, Sanders ME. Emerging issues
in probiotic safety: 2023 perspectives // Gut Microbes.
2023;15(1):2185034.
23. Adak A, Khan MR. An insight into gut microbiota and its
functionalities // Cell Mol Life Sci. 2019;76(3):473-493.
24. Liang X, Li Y, Zhao Z, Ding R, Sun J, Chi C. Safety and
efficacy of adding postbiotics in infant formula: a
systematic review and meta-analysis. Pediatr Res. 2023.
PMID: 37700163.
25. Mjelle R, Aass KR, Sjursen W, Hofsli E, Sætrom P.
sMETASeq: Combined Profiling of Microbiota and Host
Small RNAs. iScience. 2020 May 22;23(5):101131. Epub
2020 May 4. PMID: 32422595; PMCID: PMC7229328.